The multi tumor suppressor genes MTS1 (CDKN2 p16
Introduction
Current research into the molecular components and pathways controlling the cell cycle suggests that deregulation of the genes involved may result in the unchecked cell proliferation which is a common characteristic of tumor cells (Kamb, 1995; Hirama and Koeer, 1995) . Recently two cyclin dependent kinase inhibitor genes, multi tumor suppressor-1 (MTS1) (CDKN2, p16 INK4A ) and multi tumor suppressor-2 (MTS2, CDKN1, p15 INK4B ), have attracted considerable interest as they are frequently disrupted in a wide spectrum of human malignancies (Nobori et al., 1994; Kamb et al., 1994) . MTS1 and MTS2 inhibit binding of the cyclin dependent kinases CDK4 and CDK6 to cyclin D1 and thus prevent phosphorylation of the retinoblastoma protein (pRb) and subsequent progression through the G1 phase of the cell cycle. Homozygous deletion is the most common mechanism of inactivation of MTS1 and MTS2. Deletion occurs at very high frequencies in some tumor-derived cell lines and primary tumors including lung cancers, malignant gliomas and the acute lymphoblastic leukemias (ALL) (for review see Hirama and Koeer, 1995; Kamb, 1995; Cairns et al., 1995) . Somatic mutations of MTS1 are far less frequent (Pollock et al., 1996) and none have been reported in MTS2. Recently an alternative mechanism of inactivation of MTS1 and MTS2 has been established from studies of the methylation status of the promoter regions located within the 5' CpG islands of both genes. Hypermethylation of this region results in transcriptional silencing which is reversible on the addition of 5-deoxyazacytidine Gonzalez Zulueta et al., 1995) .
In this study we report the incidence of hypermethylation of MTS1 and MTS2 by investigation of the methylation status of the 5' CpG regions of both genes in 46 cases of childhood ALL. Expression of MTS1 and MTS2 was also investigated in 36 cases in which RNA was available.
Results

Southern blot analysis of MTS1 and MTS2
Southern blot analysis was performed on genomic DNA from 46 cases of childhood ALL. The results are summarized in Table 1 . Seventeen cases were of a Tcell phenotype and 29 cases of a precursor B-cell phenotype. MTS1 and MTS2 were both homozygously deleted in 16 cases (34%) (8/17 (47%) cases of T-ALL and 8/29 (28%) cases of B-ALL). Hemizygous deletion of both genes was found in 5/46 cases (11%) (one case of T-ALL and four cases of B-ALL). Two cases of T-ALL were deleted for MTS1 but not MTS2 (cases 17 and 30). Overall deletion of MTS1 (biallelic and monoallelic) was observed in 11/17 (65%) of T-ALL and 12/29 (41%) of B-ALL. MTS2 was deleted at similar frequency in cases of both T-ALL 9/17 (53%) and B-ALL 12/29 (41%).
Fluorescence in situ hybridization (FISH) analysis of MTS1 and MTS2
FISH analysis was performed on mononuclear cell (MNC) interphases from nine cases to con®rm the results of the Southern analysis for the allelic status of MTS1 and MTS2 (see Table 1 ). The sensitivity of probe P5828 (which detects both MTS1 and MTS2) was determined from co-hybridization results with D12Z1 on MNC from three normal controls (1103 cells scored) using criteria published previously (Garcia Marco et al., 1996) 
Methylation analysis of MTS1 and MTS2
The methylation status of MTS1 was investigated in the 28 cases with one or two copies of the gene. The results are summarized in Table 1 . Methylationsensitive restriction enzyme sites SacII (two sites) and SmaI (two sites) situated within the exon 1 region of MTSI were unmethylated in normal controls and in all 28 cases studied. Each case gave an expected band size of 4.3 kb for EcoRI digest alone and 400 bp and 650 bp bands for EcoRI/SmaI digests and 3.3 kb and . Twenty-six cases were also found to be unmethylated at both EagI sites. A band size of 6 kb was obtained for single HindIII digest, and HindIII/ EagI double digest gave bands of 2.1 kb and 550 bp. Two cases (24 and 31) were hypermethylated at the EagI site located in intron 1 outside the CpG island. Full methylation at this site results in the loss of the 550 bp band and the addition of a 3.9 kb band ( Figure  1 ). Methylation at this site has also been observed in normal tissue by others and was also seen in MNC from one normal control in our study.
The methylation status of MTS2 was investigated in the 28 cases studied for MTS1 and an additional two cases of T-ALL (30 in total) in which MTS1 was deleted but MTS2 was present. The results are summarized in Table 1 . The methylation-sensitive restriction enzyme site EagI located in a HindIII fragment of the 5' CpG island surrounding exon 1 of MTS2 was unmethylated in 10 cases (nine B-ALL and one T-ALL) and three normal controls. Each case gave an expected band size of 2.8 kb for the HindIII digest alone and two bands of 2.2 kb and 500 bp for HindIII/ EagI digest (examples in Figure 2 cases 6, 21, 33, 23 and 45). Eleven cases (four B-ALL and seven T-ALL) were fully methylated at this site and showed a 2.8 kb band for both single and double digests (examples are shown in Figure 2 cases 17 and 31) . The remaining nine cases (eight B-ALL and one T-ALL) showed the presence of both methylated and unmethylated alleles giving band sizes of 2.8 kb, 2.2 kb and 500 bp (examples in Figure 2 cases 14, 40 and 44) . To con®rm complete digestion of the DNA the blots were reprobed with the MTS1 probe. All cases with evidence of methylation at the EagI site in MTS2 were unmethylated at the EagI sites in MTS1 with the exception of case 31. Overall MTS2 was hypermethylated in 43% of cases (12/29 (40%) cases of B-ALL and 8/17 (47%) cases of T-ALL).
Expression of p15
INK4B and p16 INK4A mRNA by RT ± PCR
INK4B
and p16
INK4A
mRNA was investigated in 36 cases of ALL which had previously been studied for MTS1 and MTS2 deletion and hypermethylation. The results are summarized in Table 1 . Fourteen cases which were homozygously deleted for either MTS1 and/or MTS2 failed to express the relevant mRNA or had a faint positive band. It is possible that the faint signal in these samples is from the remaining MTS1/MTS2 alleles which are below the level of detection of Southern blotting. Examples are shown in Figure 3a (cases 17 and 30) and Figure 3d . The remaining 22 cases in which one or more MTS1 alleles were present expressed p16 INK4A mRNA at varying levels ranging from a faint positive band to a strong positive signal (for examples see Figure 3a cases 25, 31, 43 and Figure 3b and c). All cases in which both MTS2 alleles were present but fully methylated (four B-ALL and eight T-ALL) failed to express p15 INK4B (cases 16, 20, 25, 30, 31 and 38) or showed a faint positive band (cases 12, 17, 32, 43 and 46) . Six of these cases are shown in Figure 3a . p15 INK4B expression in seven cases with both methylated and nonmethylated MTS2 alleles was variable ranging from negative Figure 3c . Although equivalent quantities of mRNA and cDNA were used to investigate expression in this study, it should be noted that our RT ± PCR was not quantitative. However, overall the results show a good correlation with the Southern analysis and show that expression of both p15 INK4B and p16 INK4A is low in cases that are homozygously deleted, and also that p15 INK4B expression is reduced in cases where MTS2 is fully methylated.
Inactivation of MTS1 and MTS2
MTS2 inactivation by homozygous deletion (34%), hemizygous deletion (11%) or hypermethylation (43%) was observed in this series of childhood ALL. Two cases with monoallelic loss of MTS2 also showed hypermethylation of the remaining allele. Taken together these results show inactivation of MTS2 in 78% of cases. Overall inactivation of MTS1 was less frequent and was found in 50% of cases by deletion alone (39% homozygous and 11% hemizygous). No sites within the 5' CpG of MTS1 were methylated. In this study we did not investigate the mutation status of MTS1 which may account for a small percentage of MTS1 inactivation (Pollock et al., 1996) . In one case of B-ALL (case 18) both MTS1 alleles were present by Southern blot but we could not detect p16 INK4A expression. It is possible that an intragenic rearrangement or mutation may account for this ®nding.
Discussion
Abnormal patterns of DNA methylation may be found in both primary cancers and cancer-derived cell lines, and may contribute to the initiation and/or progression of tumor growth (Laird et al., 1994; Counts et al., 1995) . Hypermethylation of the CpG islands of normally unmethylated autosomal genes is associated with transcriptional silencing (Laird et al., 1994; Nagatake et al., 1996) and provides an alternative mechanism of inactivation of tumor suppressor genes such as RB, VHL, MTS1 and MTS2 (Greger et al., 1994; Herman et al., 1994 Herman et al., , 1996 Merlo et al., 1995) . MTS1 inactivation by hypermethylation has been shown in many solid tumor-derived cell lines and primary neoplasias including nasopharyngeal cancer, malignant glioma, and head and neck squamous cell carcinoma Reed et al., 1996; Lo et al., 1996; Costello et al., 1996) , but not in the myeloid or lymphoid leukemias (Jamal et al., 1996; Herman et al., 1996) . Methylation-associated transcriptional silencing of MTS2 has been demonstrated in leukemic and solid tumor cell lines and some primary malignancies (Herman et al., 1996; Gonzalez Zulueta et al., 1995) . Hypermethylation of MTS2 has also been observed in adult acute myeloid leukemia and a few cases of paediatric ALL (Herman et al., 1996) . Our study con®rms that MTS1 is not methylated in childhood acute lymphoblastic leukemia, but provides evidence of a high incidence of selective hypermethylation of MTS2.
The consistent inactivation of MTS1 by deletion, rearrangement, mutation or hypermethylation in many human tumors has suggested that MTS1 is the primary target for 9p loss. Deletions within the 9p21-22 region are often large and this has led to speculation that other genes including MTS2 may be removed only because of their proximity to the primary target gene MTS1. Previous studies of childhood ALL have reported deletion of MTS1 and MTS2 at varying frequency ranging from 15 ± 95% in T-ALL and 6 ± 45% in B-ALL (Hebert et al., 1994; Takeuchi et al., 1995; Okuda et al., 1995; Rasool et al., 1995) . In studies in which both genes were investigated MTS1 has been more commonly disrupted than MTS2 which has provided additional evidence for the predominant role of MTS1 in ALL (Haidar et al., 1995; Rasool et al., 1995) . Our study, however, suggests that methylation-associated inactivation of MTS2 in both B and T-ALL is common and taken together with deletion accounts for a greater proportion of functional loss of MTS2 compared with MTS1. Dierences in the functional activity of closely related genes is well documented (Weissmann and Weber, 1986) and although MTS1 and MTS2 belong to the same family of cyclin dependent kinase inhibitors and have similar growth suppressive activities, there is evidence thatfor p15 INK4B and p16 INK4A were exposed to Kodak BioMax MR ®lm for 24 h and 1 h for c-abl controls.
